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spread of the proven sandfl y vector 
Ph. (Laroussius) perniciosus and 
the competent sandfl y vector Ph. 
(Transphlebotomus) mascittii into 
Germany (5). It has been hypothesized 
that sandfl ies have always been 
sporadically present in central 
Europe, but that climate change will 
lead to extended distribution (10).
It is tempting to assume that 
climate change resulted in cutaneous 
leishmaniasis at 46°N in France. In 
any event, our case and those reported 
by others should make clinicians 
aware of the possibility of cutaneous 
leishmaniasis outside the well-known 
disease-endemic areas.
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Visceral 
Leishmaniasis 
during Italian 
Renaissance, 
1522–1562
To the Editor: Leishmaniasis, an 
infectious disease caused by parasites 
of the genus Leishmania, is transmitted 
to humans through the bite of a female 
sandfl y. The 3 forms of leishmaniasis 
are visceral (VL) and cutaneous (CL), 
which are typical of the Old World, 
and mucocutaneous leishmaniasis, 
which occurs primarily in Central 
and South America. VL (also called 
kala-azar) is caused by species of the 
L. donovani complex (including L. 
infantum), and CL is mainly caused 
by L. major or L. tropica (1). In Italy, 
VL and CL are caused by L. infantum. 
The origin and spread of leishmaniasis 
are a matter of debate. Widespread 
in antiquity, visceral leishmaniasis 
has been identifi ed only in mummies 
from ancient Egypt and upper 
Nubia (2). Similarly, only 4 cases of 
mucocutaneous leishmaniasis have 
been identifi ed in skulls from northern 
Chile (3).
We describe the identifi cation of 
L. infantum infection in Eleonora from 
Toledo (1522–1562), wife of Cosimo 
I de’ Medici and member of one of 
the major political Italian families 
during the Renaissance. The positive 
identifi cation of Leishmania infection 
was achieved in bone samples by 
2 independent approaches. First, a 
molecular ancient DNA (aDNA) 
analysis identifi ed a specifi c 123-bp 
fragment of a conserved region of the 
minicircle molecule of the parasite´s 
kinetoplastid mitochondrial DNA 
(4,5) which on direct sequencing 
showed a Leishmania-specifi c 
sequence compatible with L. infantum 
(Figure; online Appendix Figure, 
wwwnc.cdc.gov/EID/article/18/1/10-
2001-FA1.htm). This PCR result 
was independently replicated in 2 
laboratories and additionally supported 
by the second approach, a protein 
assay showing a concomitant positive 
reaction by detecting IgG against L. 
infantum by Western blot sodium 
dodecyl sulfate–polyacrylamide gel 
electrophoresis.
Direct sequencing of the 
Leishmania aDNA identifi ed a 
strain with high homology to L. 
infantum. Accordingly, we obtained 
a 98% concordance rate between 
our sequence and that of L. infantum 
(expect rate 6e-47, identity rate 
113/118) (online Appendix Figure). 
The rates for other Leishmania species 
indicated that concordance for those 
species was less probable.
For the protein assay, fractionated 
proteins from a lysate of late-log-
phase promastigotes of L. infantum 
ZMON-1 (World Health Organization 
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code MHOM/TN/1980/IPT-1) were 
electroblotted onto nitrocellulose 
membrane, and antibody detection was 
conducted on a Bio-Rad (Hercules, 
CA, USA) Multiscreen apparatus 
(6). Antibodies against L. infantum 
selectively reacted in a supernatant 
of protein extract from Eleonora, 
thereby confi rming the immunologic 
identifi cation of the protozoal infection. 
The response of IgG against L. infantum 
whole-parasite antigens revealed 
specifi c recognition of 8 polypeptides 
ranging from 14–16 kD to 184 kD. 
This pattern of bands is consistent with 
a symptomatic form of VL as shown by 
the 14 to 16–kD bands.
Although it was initially proposed 
that the antigenicity of ancient proteins 
may be altered by diagenesis, further 
investigations have shown that ancient 
immunoglobulins can persist across 
geologic times (7). Potential pitfalls 
in protein-based detection of ancient 
pathogens have been addressed by 
incorporating proper controls during 
the analysis. False-positive data, which 
can result either from contamination of 
ancient material by modern materials 
or from lack of microbe specifi city 
of the test (7), have been ruled out by 
the parallel testing of several blanks 
(buffer without ancient material) and 
by testing, in parallel, samples of 
ancient bone tissue harvested from 
persons who died of known diseases 
other than leishmaniasis (e.g., plague). 
All negative controls used in aDNA 
and protein research and all blanks 
yielded negative results. To avoid 
contamination, we used no positive 
controls.
The disease history of Eleonora 
from Toledo is as follows. Her clinical 
history was dominated by a large 
number of pregnancies. When 18–32 
years of age, she gave birth to as many 
as 11 infants. On the basis of additional 
clinical reports of court doctors, it was 
assumed that pulmonary tuberculosis 
developed when she was 29 years of 
age (8). In the last years of her life, 
Eleonora from Toledo had various 
severe ailments. Irregular bouts of 
fever, wasting and constant vomiting, 
stomach pain, weight loss, anemia, 
and hemorrhage were recorded. 
Autopsy revealed that her most 
damaged organs were the lungs and 
that the lung lesions were consistent 
with a chronic pulmonary infection. 
Hepatomagaly and splenomegaly 
were also recorded (9). Although 
these signs and symptoms could 
have come from the tuberculosis 
infection, they are also consistent with 
those in patients with symptomatic 
VL, i.e., progressive fever, weight 
loss, splenomegaly, hepatomegaly, 
hypergammaglobulinemia, and pan-
cytopenia. Complications include 
immunosuppression, secondary bac-
terial infections, hemorrhage, and 
anemia (10). All these observations 
lend support to the notion that 
Eleonora from Toledo was not 
immunocompetent. In addition to a 
supposed tuberculosis co-infection, 
VL infection may have been a key 
event leading to her death at age 40. 
Our molecular and serologic 
identifi cation of Leishmania infection 
in a historically prominent person from 
southern Europe has major relevance. 
This information might be useful 
for monitoring the infection and its 
pathogen throughout history and might 
provide data on the host–pathogen 
interaction over different periods.
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Figure. PCR amplifi cation of a 123-bp fragment of kinetoplastid mitochondrial DNA of 
Leishmania spp. from Eleonora from Toledo (lane 6, arrow). Lane 1, molecular mass 
standard; lanes 2–5, ancient controls; lanes 7–9, blank controls.
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Plague Epidemic 
in the Kingdom of 
Naples, 1656–1658
To the Editor: In 1656, an 
epidemic of plague occurred in the 
Kingdom of Naples, Italy. Earlier the 
disease had spread from Algiers to 
Spain; in June 1647, it appeared in 
Valencia, and in the spring of 1648, 
it appeared in Aragon and several 
other Spanish areas of Valencia, 
Andalusia, and Catalonia. In 1652, 
plague had spread to Sardinia and 
then to the cities and territories of 
Naples, Rome, and Genoa. Within 
the Kingdom of Naples, plague fi rst 
reached the town of Naples in the 
spring of 1656. Despite measures 
restricting population movement, by 
the summer of 1656, the disease had 
reached several provinces in southern 
Italy (1,2).
Historical records indicate that 
the epidemic in Barletta, in southern 
Italy, developed after the arrival of 
a ship from Naples. On May 26, 
1656, the ship Sant’ Andrea arrived 
from Naples at the port of Barletta. 
However, after sanitary inspection, 
the ship was prevented from landing 
and obliged to depart, but this measure 
was not suffi cient to prevent the 
disease from entering the port. The 
Barletta epidemic peaked in October, 
after which the number of cases 
diminished; and on June 22, 1657, 
Barletta was declared free of plague. 
Of this city’s original population of 
20,000, the disease killed 7,000–
12,000 persons. It is hypothesized that 
throughout the Kingdom, the plague 
killed ≈1,250,000 persons (1,2).
Since the 14th century, noble 
families of Barletta had been buried in 
tombs in underground tunnels of Sant’ 
Andrea church. During restoration of 
the church in 2009, more underground 
tunnels containing many skeletons 
were discovered. It has been 
hypothesized that the church had also 
been used as a cemetery during the 
plague epidemic. During an inspection 
of the skeletons, 5 skulls of young 
persons were identifi ed and collected. 
For a negative control, the skull of a 
person buried in a tomb before the 
epidemic was also collected.
The skulls were radiographed 
to identify unerupted teeth (Figure), 
which were then aseptically extracted. 
After classifi cation, each tooth was 
cut along a sagittal line to uncover the 
dental pulp, which was then hydrated 
in sterile phosphate-buffered saline 
(pH 7.2) for 48 h at 37°C. The DNA 
was extracted by using DNAeasy 
Blood and Tissue Kits (QIAGEN, 
Hilden, Germany) and by modifying 
the fi rst step, which was conducted 
overnight at 56°C with 600 μL of 
ATL buffer (QIAGEN) and 50 μL of 
proteinase K. To verify the presence of 
inhibiting substance, the control DNA 
extracts were screened by using a PCR 
for human mitochondrial DNA (3).
To investigate the cause of the 
deaths, we adopted a PCR suicide 
method and searched for Yersinia 
pestis. We amplifi ed the pla gene for Y. 
pestis by using Sybr green PCR in real 
time with a modifi cation of a previous 
protocol (4) coupled with conventional 
PCR according to Drancourt et al. (5). 
Conventional PCRs were adopted 
for Bacillus anthracis by targeting 
the pag and capC genes (6) and for 
Salmonella enterica serovar Typhi by 
targeting the narG gene (7). To prevent 
cross-contamination, we conducted 
all PCRs with a negative control and 
in the absence of positive controls. 
Melting curve analysis and agarose 
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